KRAS and colorectal cancer: Given the scarcity of such research from Romania in the scientific literature, our study aims to explore possible correlations between demographic, clinical, and paraclinical variables and the outcomes in a metastatic KRAS-mutant and KRAS wild-type colorectal cancer population of 225 adult patients diagnosed with stage IV colorectal cancer and treated at the Coltea Clinical Hospital, Bucharest, Romania, a tertiary level center.